Return on equity ROE
12 %
Last period ROE
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Novartis
Company Analysis
500672.BO valuation, rating, competitors, insights and company profile
Eyestock Rating
500672.BO financial analysis by Eyestock methodology
Valuation
500672.BO valuation using historical relative method
Financials
500672.BO revenue, earnings, ROE, ROIC and other financials
Statements
500672.BO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
500672.BO dividend yield and annual dividend
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
What is ROE of Novartis ?
Novartis`s ROE for the last twelve months ended 2024-03-31 is 12 %